|
OR |
95% CI |
p value |
OR |
95% CI |
p value |
Model using echocardiographic data |
Model using
echocardiographic data |
Model using echocardiographic data |
Model using echocardiographic data |
Model using
echocardiographic data |
Model using echocardiographic data |
Model using echocardiographic data |
Pre TR score |
2.3 |
1.3–4.1 |
0.0025 |
1.8 |
1.0–3.4 |
0.042 |
PH (estimated RVSP of >40 mmHg) |
2.6 |
1.2–6.0 |
0.021 |
1.9 |
0.79–4.6 |
0.15 |
RA minimum (4-chamber view) |
1.0 |
0.99–1.1 |
0.14 |
|
|
|
RA maximum (4-chamber view) |
1.0 |
0.99–1.0 |
0.28 |
|
|
|
TRPG |
1.0 |
0.99–1.0 |
0.20 |
|
|
|
LVDd (parasternal long-axis view) |
0.99 |
0.94–1.0 |
0.57 |
|
|
|
LVDs (parasternal long-axis view) |
0.98 |
0.95–1.0 |
0.61 |
|
|
|
TV diameter, mm/m2 |
0.97 |
0.89-1.1 |
0.44 |
|
|
|
Model using clinical data |
Model using clinical data |
Model using clinical data |
Model using clinical
data |
Model using clinical data |
Model using
clinical data |
Model using clinical data |
Valve with two posterior leaflets |
3.4 |
1.5–7.7 |
0.0036 |
2.6 |
1.1–6.1 |
0.033 |
Male sex |
0.56 |
0.26–1.3 |
0.16 |
|
|
|
Body surface area |
0.22 |
0.026–1.9 |
0.16 |
|
|
|
Age |
1.0 |
0.96–1.1 |
0.75 |
|
|
|
NYHA class ≥II heart failure |
2.0 |
0.43–9.5 |
0.33 |
|
|
|
Atrial fibrillation |
1.5 |
0.61–3.6 |
0.38 |
|
|
|
Dyslipidemia |
2.0 |
0.82–4.6 |
0.13 |
|
|
|
Ischemic heart disease |
2.3 |
0.93–5.7 |
0.078 |
|
|
|